Literature DB >> 16281886

Maximizing power and minimizing treatment failures in clinical trials.

William F Rosenberger1, Feifang Huc.   

Abstract

BACKGROUND: Response-adaptive randomization procedures have a long history in the theoretical statistics literature over the past four decades. The main idea historically was to develop randomization procedures that place fewer patients on the inferior treatment. More recent research has changed the main focus to that of usual considerations in typical clinical trials: power, sample size, expected treatment failures, maintaining randomization, among others.
METHODS: We describe response-adaptive randomization procedures for simple clinical trials comparing two binomial success probabilities, including the randomized play-the-winner rule, the drop-the-loser rule, and a modification of the doubly-adaptive biased coin design. We treat as our principal goal minimizing expected treatment failures while preserving power and randomization. Based on some recent theoretical literature, the basic guidelines for selecting an appropriate procedure include targeting optimal allocation, having small variability, and preserving randomization. We use simulation to compare power and expected treatment failures according to these guidelines.
RESULTS: When the two treatments had high probabilities (> 0.5) of success, the randomized play-the-winner rule was less powerful than complete randomization and the drop-the-loser rule by 1-3 percent with slightly larger expected number of treatment failures than the drop-the-loser rule. For all the success probabilities we examined, the drop-the-loser rule was within 1 percent of the power of complete randomization with a modest reduction of treatment failures. The doubly-adaptive biased coin design was as powerful or slightly more powerful than complete randomization in every case and expected treatment failures were always less, with modest reductions of the order of 0.3 percent to 8.3 percent.
CONCLUSIONS: We conclude that the drop-the-loser rule and a modification of the doubly-adaptive biased coin design are the preferred procedures, and simulations show that these procedures yield a modest reduction in expected treatment failures while preserving power over complete randomization.

Entities:  

Mesh:

Year:  2004        PMID: 16281886     DOI: 10.1191/1740774504cn016oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  9 in total

1.  Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population Group.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Andrew C Hooker
Journal:  AAPS J       Date:  2018-07-19       Impact factor: 4.009

2.  Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial.

Authors:  Wenle Zhao; Valerie Durkalski
Journal:  Stat Med       Date:  2014-05-22       Impact factor: 2.373

3.  A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials.

Authors:  Amy S Nowacki; Wenle Zhao; Yuko Y Palesch
Journal:  Stat Methods Med Res       Date:  2015-01-12       Impact factor: 3.021

4.  Implementing Optimal Allocation in Clinical Trials with Multiple Endpoints.

Authors:  Lu Wang; Yong Chen; Hongjian Zhu
Journal:  J Stat Plan Inference       Date:  2016-10-07       Impact factor: 1.111

5.  RARtool: A MATLAB Software Package for Designing Response-Adaptive Randomized Clinical Trials with Time-to-Event Outcomes.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Weng Kee Wong
Journal:  J Stat Softw       Date:  2015-08-01       Impact factor: 6.440

6.  Outcome-adaptive randomization for a delayed outcome with a short-term predictor: imputation-based designs.

Authors:  Mi-Ok Kim; Chunyan Liu; Feifang Hu; J Jack Lee
Journal:  Stat Med       Date:  2014-05-29       Impact factor: 2.373

7.  Translational Research in Oncology: Implications for Palliative Care.

Authors:  Arunangshu Ghoshal
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

8.  Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.

Authors:  Caitlyn Meinzer; Renee Martin; Jose I Suarez
Journal:  Trials       Date:  2017-09-08       Impact factor: 2.279

9.  Bayesian selective response-adaptive design using the historical control.

Authors:  Mi-Ok Kim; Nusrat Harun; Chunyan Liu; Jane C Khoury; Joseph P Broderick
Journal:  Stat Med       Date:  2018-06-13       Impact factor: 2.373

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.